IRIS Accounts Production v25.1.4.42 Tribuco Ltd 15311814 Board of Directors Board of Directors 27.11.23 31.12.24 31.12.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh153118142023-11-26153118142024-12-31153118142023-11-272024-12-31153118142023-11-261531181412023-11-272024-12-3115311814ns15:EnglandWales2023-11-272024-12-3115311814ns14:PoundSterling2023-11-272024-12-3115311814ns10:Director12023-11-272024-12-3115311814ns10:Director22023-11-272024-12-3115311814ns10:PrivateLimitedCompanyLtd2023-11-272024-12-3115311814ns10:SmallEntities2023-11-272024-12-3115311814ns10:AuditExempt-NoAccountantsReport2023-11-272024-12-3115311814ns10:SmallCompaniesRegimeForDirectorsReport2023-11-272024-12-3115311814ns10:SmallCompaniesRegimeForAccounts2023-11-272024-12-3115311814ns10:FullAccounts2023-11-272024-12-311531181412023-11-272024-12-3115311814ns10:Director32023-11-272024-12-3115311814ns10:RegisteredOffice2023-11-272024-12-3115311814ns5:CurrentFinancialInstruments2024-12-3115311814ns5:ShareCapital2024-12-3115311814ns5:SharePremium2024-12-3115311814ns5:FurtherSpecificReserve1ComponentTotalEquity2024-12-3115311814ns5:RetainedEarningsAccumulatedLosses2024-12-3115311814ns5:NetGoodwill2023-11-272024-12-3115311814ns5:ComputerSoftware2023-11-272024-12-3115311814ns5:PlantMachinery2023-11-272024-12-3115311814ns5:IntangibleAssetsOtherThanGoodwill2023-11-272024-12-3115311814ns5:NetGoodwill2024-12-3115311814ns5:IntangibleAssetsOtherThanGoodwill2024-12-3115311814ns5:PlantMachinery2024-12-3115311814ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3115311814ns10:Director222023-11-2615311814ns10:Director222023-11-272024-12-3115311814ns10:Director222024-12-31153118143ns10:Director32023-11-26153118143ns10:Director32023-11-272024-12-31153118143ns10:Director32024-12-311531181412023-11-272024-12-31
REGISTERED NUMBER: 15311814 (England and Wales)






















Unaudited Financial Statements

for the period

27 November 2023 to 31 December 2024

for

Qured Health Ltd

Qured Health Ltd (Registered number: 15311814)






Contents of the Financial Statements
for the period 27 November 2023 to 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Qured Health Ltd

Company Information
for the period 27 November 2023 to 31 December 2024







DIRECTORS: Ms E S Swanton
A Templeton
Dr S Khemka





REGISTERED OFFICE: 71-75 Shelton Street
Covent Garden
London
WC2H 9JQ





REGISTERED NUMBER: 15311814 (England and Wales)





ACCOUNTANTS: Bennett Brooks & Co Ltd
Chartered Accountants
Suite 1, First Floor
Coachworks Arcade
Northgate Street
Chester
Cheshire
CH1 2EY

Qured Health Ltd (Registered number: 15311814)

Balance Sheet
31 December 2024

Notes £
FIXED ASSETS
Intangible assets 4 139,111
Tangible assets 5 4,116
143,227

CURRENT ASSETS
Stocks 39,359
Debtors 6 31,481
Cash at bank 341,687
412,527
CREDITORS
Amounts falling due within one year 7 (331,806 )
NET CURRENT ASSETS 80,721
TOTAL ASSETS LESS CURRENT
LIABILITIES

223,948

CAPITAL AND RESERVES
Called up share capital 2
Share premium 867,302
Other reserves 95,000
Retained earnings (738,356 )
223,948

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Qured Health Ltd (Registered number: 15311814)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 April 2025 and were signed on its behalf by:




Ms E S Swanton - Director



A Templeton - Director


Qured Health Ltd (Registered number: 15311814)

Notes to the Financial Statements
for the period 27 November 2023 to 31 December 2024

1. STATUTORY INFORMATION

Qured Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of Health Technologies Limited in 2024, is being amortised evenly over its estimated useful life of 3.5 years.

Intangible assets - computer software
Research and Development Costs: The company has capitalised software development costs in accordance with FRS 102 Section 1A. The criteria for capitalisation include the technical feasibility of completing the asset, the intention to complete and use or sell the asset, the ability to use or sell the asset, the probable future economic benefits, the availability of resources to complete the development, and the reliable measurement of the expenditure.

Amortisation: The capitalised software development costs are amortised over their useful life, which is estimated to be 6 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Qured Health Ltd (Registered number: 15311814)

Notes to the Financial Statements - continued
for the period 27 November 2023 to 31 December 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 12 .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£ £ £
COST
Additions 6,000 148,197 154,197
At 31 December 2024 6,000 148,197 154,197
AMORTISATION
Charge for period 1,663 13,423 15,086
At 31 December 2024 1,663 13,423 15,086
NET BOOK VALUE
At 31 December 2024 4,337 134,774 139,111

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
Additions 12,000
At 31 December 2024 12,000
DEPRECIATION
Charge for period 7,884
At 31 December 2024 7,884
NET BOOK VALUE
At 31 December 2024 4,116

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£
Trade debtors 15,300
Other debtors 16,181
31,481

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£
Trade creditors 30,848
Taxation and social security 136,944
Other creditors 164,014
331,806

Qured Health Ltd (Registered number: 15311814)

Notes to the Financial Statements - continued
for the period 27 November 2023 to 31 December 2024

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 31 December 2024:

£
A Templeton
Balance outstanding at start of period -
Amounts advanced 1
Amounts repaid -
Amounts written off -
Amounts waived -
Balance outstanding at end of period 1

Dr S Khemka
Balance outstanding at start of period -
Amounts advanced 10,000
Amounts repaid (10,000 )
Amounts written off -
Amounts waived -
Balance outstanding at end of period -

The above advances are unsecured, interest free and repayable on demand.

9. ULTIMATE CONTROLLING PARTY

A Templeton, a director, is the controlling party by virtue of owning more than 50% of the issued share capital.